Life sciences organizations face many complexities and challenges associated with spend transparency regulations and reporting obligations, including navigating the intricacies of timing to complete reporting, establishing efficient and accurate reporting methodologies, and anticipating forthcoming developments. Furthermore, managing these complexities while extracting tangible value in terms of data analytics from a compliance or commercial operations perspective remain key challenges for our industry.  

Join Baker Tilly for an informative webinar where our team of life sciences professionals will discuss the evolving best practices in addressing the operational burden of accurate, complete and timely spend transparency reporting. Our team will also discuss practical use cases of insightful data analytics and ways life sciences leaders are leveraging data to make proactive compliance and commercial decisions. Additionally, we will delve into optimizing effectiveness of HCP engagement strategies through combining spend transparency data analytics with other critical data components such as fair market value (FMV), key opinion leader (KOL) identification data, additional speaker bureau engagement data and more. The discussion will conclude by examining data trends from 2023 and identifying categories of HCPs within compliance programs that are expected to face heightened scrutiny in 2024.